Mehrnaz Mona Ameli
CIK 1625720 · View on SEC EDGAR ↗
Insider
First SEC filing: Nov. 17, 2017 · Latest: Nov. 17, 2017
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 11 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 17, 2017 | MED | F | 800 | $67.03 | $53,624 | 10,809 Direct | -6.89% | Disposed | -82.5% (price as of 2026-08-21) |
| Feb. 16, 2017 | MED | A | 7,500 | — | — | 7,500 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 16, 2017 | MED | A | 37,950 | — | — | 37,950 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 16, 2017 | MED | A | 2,120 | — | — | 9,489 Direct | +28.77% | Acquired | (price as of 2026-08-21) |
| Feb. 16, 2017 | MED | A | 2,375 | — | — | 7,369 Direct | +47.56% | Acquired | (price as of 2026-08-21) |
| Dec. 31, 2016 | MED | F | 837 | $41.63 | $34,844 | 4,994 Direct | -14.35% | Disposed | -71.8% (price as of 2026-08-21) |
| March 25, 2016 | MED | A | 2,000 | — | — | 4,000 Direct | +100.00% | Acquired | (price as of 2026-08-21) |
| Feb. 4, 2016 | MED | A | 1,431 | — | — | 5,831 Direct | +32.52% | Acquired | (price as of 2026-08-21) |
| Nov. 17, 2015 | MED | F | 600 | $30.24 | $18,144 | 4,400 Direct | -12.00% | Disposed | -61.1% (price as of 2026-08-21) |
| Feb. 17, 2015 | MED | A | 2,000 | — | — | 2,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Nov. 17, 2014 | MED | A | 5,000 | — | — | 5,000 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 16, 2017 | MED | Stock Options | Common Stock (7,500) | $44.73 | Feb. 16, 2027 | 7,500 | Acquired |
| Feb. 16, 2017 | MED | Performance Restricted Stock Units | Common Stock (37,950) | — | — | 37,950 | Acquired |
| March 25, 2016 | MED | Stock Option | Common Stock (2,000) | $29.23 | March 25, 2026 | 2,000 | Acquired |
| Feb. 17, 2015 | MED | Stock Options | Common Stock (2,000) | $31.55 | Feb. 17, 2025 | 2,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).